MedTrace Logo

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

NCT07629349 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-06-05

No results posted yet for this study

Summary

The goal of this observational study is to improve the detection of dementia with Lewy bodies (DLB) and its prodromal phases, as well as advancing our current understanding of biological mechanisms and therapeutic options. The data is acquired at cognitive clinics in Stockholm (Sweden) and combined with national and international data to increase statistical power, representativeness and replication of results. Participants undergo collection of clinical assessments, neuroimaging and fluid biomarkers.

Conditions

  • Dementia With Lewy Bodies (DLB)
  • Mild Cognitive Impairment (MCI)
  • Cognitively Unimpaired
  • Other Dementias

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2031-03-01
Completion
2031-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07629349 on ClinicalTrials.gov